With continued investment in mRNA research, Donald Trump could turn the stalemate against cancer into a decisive breakthrough ...

Generation LNP Advancements enhance potency and safety, expand delivery beyond the liver, and enable broader therapeutic ...

The mRNA vaccine drug development market presents growth opportunities through increased investment, diverse therapeutic applications, and scalable production demand. Key prospects include strategic ...

“Enteromix is an oncolytic vaccine made from a mixture of enteroviruses that selectively infect tumour cells and stimulate ...

Now, there’s a new player in town called CancerVax, and it’s getting a lot of attention. This article is going to look at ...

Recently, antivaxxers have been expressing their impatience with HHS Secretary Robert F. Kennedy Jr.'s progress eliminating ...

Researchers showed that an mRNA influenza vaccine delivered with their new lipid nanoparticle could generate the same immune ...

The study was published in Nature Biotechnology last month and marks a shift in scientists’ understanding of how to ...

The story of the pharmaceutical company Moderna almost reads like a Hollywood screenplay. In its relatively short life, it ...

There’s some really interesting news coming out of the cancer research world lately, specifically about something called ...

The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...